Stay updated on Long-term Baricitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedUpdates the displayed ClinicalTrials.gov page revision/build number from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded Moravian-Silesian Region and Nový Jičín (Moravian-Silesian Region, Czechia, 741 01); replaced Moravskoslezský kraj, Czechia, 741 01 with Moravian-Silesian Region entry; revision updated from 3.5.0 to 3.5.2.SummaryDifference0.0%

- Check48 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the Locations list.SummaryDifference0.0%

- Check55 days agoChange DetectedUpdated page revision label from v3.4.3 to v3.5.0. No study content or results appear to be altered.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.0%

- Check91 days agoChange DetectedA new revision label, Revision: v3.4.2, is now shown. The page also removes the previous funding-status notice and the earlier Revision: v3.4.1 reference.SummaryDifference0.1%

Stay in the know with updates to Long-term Baricitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page.